Sunil Rao in conversation with Thomas Lüscher
INNOVATE PCI: A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous...
» More
Sunil Rao in conversation with Thomas Lüscher
INNOVATE PCI: A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibtor in Non-Urgent PCI.